A systematic review and meta-analysis of alpha-adrenergic antagonists for the treatment of pain in chronic prostatitis
World Journal of Urology · 01.04.2025 · 43 (1)
DOI: 10.1007/s00345-025-05575-8 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift World Journal of Urology, online erschienen am 01.04.2025. Verfasst von Anthony Carona und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of Houston, Tilman J. Fertitta Family College of Medicine, 5055 Medical Circle, Houston, TX, 77204, USA. Hauptthemen laut MEDLINE: Prostatitis, Adrenergic alpha-Antagonists, Chronic Pain, Pelvic Pain. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) is a debilitating condition affecting 2-10% of men globally. Its symptoms, including pelvic pain, urinary problems, and reduced quality of life, vary widely. Despite extensive research, a definitive treatment remains elusive. Alpha-adrenergic antagonists are frequently used to manage urinary symptoms, while analgesics are employed for pain. However, the long-term efficacy of alpha-adrenergic antagonists for pelvic pain requires further investigation. CP/CPPS places a significant burden on healthcare systems and the economy. This systematic review aims to evaluate the effectiveness of alpha-adrenergic antagonists in reducing pain symptoms in men with CP/CPPS compared to placebo. METHODS: A systematic search of randomized, placebo-controlled trials evaluating the effectiveness of alpha-adrenergic antagonists for the treatment of pain in CP/CPPS was conducted and captured all available studies (n = 680). After application of exclusion criteria, five studies were identified as suitable for inclusion. RESULTS: Four papers consisting of five studies, containing a total of 578 participants, were evaluated. The combined effects found no difference in pain relief between treated and control subjects for the data from the five studies in the meta-analysis (P = 0.106), with the 95% CI for the random effects model containing a value of 0.00. CONCLUSION: In adults with CP/CPPS, alpha-adrenergic antagonists were ineffective as monotherapy to treat pain. Further studies are needed to address possible confounding variables for alpha-adrenergic antagonist efficacy. These findings suggest that alpha-adrenergic antagonists as monotherapy are not effective for pain reduction in CP/CPPS and highlight the need for further research to explore combination therapies or other treatment modalities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Houston, Tilman J. Fertitta Family College of Medicine, 5055 Medical Circle, Houston, TX, 77204, USA.
- Washington University School of Medicine, St. Louis, USA.
- University of Houston, Tilman J. Fertitta Family College of Medicine, 5055 Medical Circle, Houston, TX, 77204, USA. kcrowland@uh.edu.
Zitieren
APA
Carona, A., Jacobson, D., Hildebolt, C., & Rowland, K. (2025). A systematic review and meta-analysis of alpha-adrenergic antagonists for the treatment of pain in chronic prostatitis. World Journal of Urology, 43(1). https://doi.org/10.1007/s00345-025-05575-8
Vancouver
Carona A, Jacobson D, Hildebolt C, Rowland K. A systematic review and meta-analysis of alpha-adrenergic antagonists for the treatment of pain in chronic prostatitis. World Journal of Urology. 2025;43(1). doi:10.1007/s00345-025-05575-8
BibTeX
@article{Carona2025,
author = {Carona, Anthony and Jacobson, David and Hildebolt, Charles and Rowland, Kevin},
title = {A systematic review and meta-analysis of alpha-adrenergic antagonists for the treatment of pain in chronic prostatitis},
journal = {World Journal of Urology},
year = {2025},
volume = {43},
number = {1},
doi = {10.1007/s00345-025-05575-8}
}
EUVIMED